2005
DOI: 10.1016/j.eupc.2005.05.012
|View full text |Cite
|
Sign up to set email alerts
|

Anticoagulation in atrial fibrillation and flutter

Abstract: Atrial fibrillation and atrial flutter are important risk factors for stroke. Based on a literature search, pathogenesis of thromboembolism, risk assessment in patients, efficacy of anticoagulation therapy and its alternatives are discussed. Special emphasis is put on issues like paroxysmal atrial fibrillation, atrial flutter and anticoagulation surrounding catheter ablation and cardioversion. A strategy for anticoagulation around the time of pulmonary vein ablation is suggested.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0
5

Year Published

2006
2006
2023
2023

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(13 citation statements)
references
References 90 publications
(70 reference statements)
0
8
0
5
Order By: Relevance
“…It is appropriate to prescribe oral anticoagulant before and to re-initiate it after the procedure [13]. Healthcare providers should encourage patients to monitor their pulse for irregularity, and this may serve as an initial screening tool for asymptomatic AF episodes [11].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…It is appropriate to prescribe oral anticoagulant before and to re-initiate it after the procedure [13]. Healthcare providers should encourage patients to monitor their pulse for irregularity, and this may serve as an initial screening tool for asymptomatic AF episodes [11].…”
Section: Discussionmentioning
confidence: 99%
“…Following the previous relative literature[1, 8, 9, 1113], a structured questionnaire was accordingly designed specifically for patients with AF undergoing RFCA based on face to face interview results of 30 patients with AF undergoing RFCA and the advice by experts and panel discussions. These allowed us to check if the questions were well understood and all pertinent to our project.…”
Section: Methodsmentioning
confidence: 99%
“…No clear recommendations are available regarding the use of anticoagulation after a successful pulmonary vein isolation procedure, but it seems logical to continue oral anticoagulant drugs for some time: experienced groups continue anticoagulation for at least three to six months after successful ablation [2,3,17]. Withdrawal of anticoagulant drugs after the procedure can be considered after ruling out recurrences of paroxysmal atrial fibrillation and after follow-up TEE confirmation of thrombus absence.…”
Section: Discussionmentioning
confidence: 96%
“…VKAs are effective for the prevention and treatment of many thrombotic disorders such as atrial fibrillation 5. However, their management is difficult because of their narrow therapeutic index and a high risk of bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…A report obtained from the nearby hospital confirmed the flutter ablation 3 months after the development of the atrial flutter. On the basis of this information, considering the patient's poor knowledge of his VKA therapy and in accordance with the treatment recommendations following flutter ablation, the pharmacy resident suggested that the anticoagulant should be stopped and antiplatelet treatment (aspirin 75 mg once a day) be commenced 5. The patient's general practitioner and cardiologist were informed and gave their agreement.…”
Section: Case Descriptionmentioning
confidence: 99%